The Department of Pharmaceuticals constituted a committee under Dr. M. Srinivas to examine the regulatory framework governing pharmaceutical marketing practices and recommend measures to address unethical promotion. Pharmaceutical marketing can influence prescribing behaviour, the selection of medicines and the relationship between healthcare professionals and drug manufacturers. Ethical promotion is important because patients depend on medical advice when making treatment decisions. Misleading claims or inappropriate incentives can undermine trust and increase the risk of irrational medicine use. Clear rules, transparent disclosure, professional accountability and effective grievance mechanisms can help improve standards. Regulatory reform should protect patients while allowing accurate scientific information about medicines to reach healthcare professionals.